We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why You Should Add Enphase Energy to Your Portfolio
Read MoreHide Full Article
Earnings estimates for Enphase Energy, Inc (ENPH - Free Report) have been revised upward over the past 90 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings moved up by 28.6% and 20% to 9 cents and 30 cents, respectively.
Enphase Energy, based in Petaluma, CA, designs, develops and sells microinverter systems for residential as well as commercial markets in the United States and internationally.
Let’s focus on factors that make Enphase Energy a profitable bet.
Earnings Surprise History and Price Performance
Enphase Energy has an average four-quarter positive earnings surprise of 44.13%. The company’s shares have surged 751.1% in a year’s time compared with the industry’s rise of 23.6%. The stock carries a Zacks Rank #2 (Buy).
VGM Score
The stock has an impressive VGM Score of B. Here V stands for Value, G for Growth and M for Momentum with the score being a weighted combination of all three factors. Back tested results show that stocks with a favorable VGM Score of A or B coupled with a bullish Zacks Rank are the best investment options.
Enphase’s Microinverter System
The Enphase IQ Microinverter System enables the simplification of solar installations. It provides a complete alternating current (AC) solution that uses no high-voltage direct current (DC) and provides a safe solar solution for homeowners. The system’s burst technology enables microinverters to produce more energy during low-light conditions.
Growth Projections
The Zacks Consensus Estimate for current-year earnings per share is pegged at 9 cents per share, reflecting a significant year-over-year surge of 136.0%.
For 2019, the consensus estimate for EPS is pegged at 30 cents per share, depicting a 233.3% year-over-year rise.
Murphy Oil delivered a positive earnings surprise of 4.55% in the last earnings report. Its 2018 estimates have increased 21.9% to $1.67 in the last 60 days.
Devon Energy delivered a positive earnings surprise of 5.26% in the last earnings report. Its 2018 estimates have surged 36.6% to $1.83 in the last 60 days.
Cheniere Energy delivered a positive earnings surprise of 90.32% in the last earnings report. Its 2018 estimates have moved up 7.8% to $1.93 in the last 60 days.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Here's Why You Should Add Enphase Energy to Your Portfolio
Earnings estimates for Enphase Energy, Inc (ENPH - Free Report) have been revised upward over the past 90 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings moved up by 28.6% and 20% to 9 cents and 30 cents, respectively.
Enphase Energy, based in Petaluma, CA, designs, develops and sells microinverter systems for residential as well as commercial markets in the United States and internationally.
Let’s focus on factors that make Enphase Energy a profitable bet.
Earnings Surprise History and Price Performance
Enphase Energy has an average four-quarter positive earnings surprise of 44.13%. The company’s shares have surged 751.1% in a year’s time compared with the industry’s rise of 23.6%. The stock carries a Zacks Rank #2 (Buy).
VGM Score
The stock has an impressive VGM Score of B. Here V stands for Value, G for Growth and M for Momentum with the score being a weighted combination of all three factors. Back tested results show that stocks with a favorable VGM Score of A or B coupled with a bullish Zacks Rank are the best investment options.
Enphase’s Microinverter System
The Enphase IQ Microinverter System enables the simplification of solar installations. It provides a complete alternating current (AC) solution that uses no high-voltage direct current (DC) and provides a safe solar solution for homeowners. The system’s burst technology enables microinverters to produce more energy during low-light conditions.
Growth Projections
The Zacks Consensus Estimate for current-year earnings per share is pegged at 9 cents per share, reflecting a significant year-over-year surge of 136.0%.
For 2019, the consensus estimate for EPS is pegged at 30 cents per share, depicting a 233.3% year-over-year rise.
Other Stocks to Consider
A few other top-ranked stocks from the same sector are Devon Energy (DVN - Free Report) , Murphy Oil Corporation (MUR - Free Report) and Cheniere Energy, Inc (LNG - Free Report) . Murphy Oil sports a Zacks Rank #1 (Strong Buy). Devon Energy and Cheniere Energy carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Murphy Oil delivered a positive earnings surprise of 4.55% in the last earnings report. Its 2018 estimates have increased 21.9% to $1.67 in the last 60 days.
Devon Energy delivered a positive earnings surprise of 5.26% in the last earnings report. Its 2018 estimates have surged 36.6% to $1.83 in the last 60 days.
Cheniere Energy delivered a positive earnings surprise of 90.32% in the last earnings report. Its 2018 estimates have moved up 7.8% to $1.93 in the last 60 days.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>